Chief Executive Officer
Cardialysis B.V.
Rotterdam, Zuid-Holland, Netherlands
Dr. Ernest Spitzer is the Chief Executive Officer at Cardialysis and Director of the European Cardiovascular Research Institute, both based in Rotterdam, the Netherlands. Dr. Spitzer oversees medical and clinical trial expertise in trial design, cardiovascular core laboratories, endpoint adjudication, data and safety monitoring boards, medical monitoring, and safety reporting, in close collaboration with operational and scientific experts. He has contributed with 80+ articles in peer-reviewed journals and is Board Member of the Academic Research Consortium and the EU-MDR Cardiovascular Collaboratory.
Disclosure(s): Abbott Labs: Grant/Research Support (Terminated, December 31, 2023); Biosensors International: Grant/Research Support (Ongoing); Boston Scientific: Grant/Research Support (Ongoing); Cardialysis: Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Edwards Lifesciences LLC: Grant/Research Support (Ongoing); Medtronic: Grant/Research Support (Ongoing); MicroPort Medical: Grant/Research Support (Terminated, June 30, 2024); Philips Healthcare: Grant/Research Support (Ongoing); Pie Medical: Grant/Research Support (Ongoing); shenqi Medical Technology: Grant/Research Support (Ongoing); Siemens: Grant/Research Support (Ongoing)
Sunday, March 9, 2025
2:32 PM – 2:40 PM ET
Discussion | Closing the Disparity in Research
Sunday, March 9, 2025
2:56 PM – 3:15 PM ET
Global Collaborative Structured Evidence Collection | The European Experience
Tuesday, March 11, 2025
11:22 AM – 11:30 AM ET
Panel Discussion | Digital Heath Apps in Clinical Trials: Ready for Prime Time?
Tuesday, March 11, 2025
11:30 AM – 12:00 PM ET